The DFU trial was designed to justify outpatient reimbursement for BTM. The trial was terminated and they discussed replacing with another trial, but haven't announced a new trial. Other products (Integra) have received outpatient approval without going through a clinical trial. Perhaps they're seeking outpatient approval through another mechanism.
PNV - Banter and General Comments, page-11860
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
0.020(0.86%) |
Mkt cap ! $1.622B | |||
| Open | High | Low | Value | Volume |
| $2.37 | $2.40 | $2.34 | $2.822M | 1.196M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13436 | $2.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.36 | 11159 | 4 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |